COMMUNIQUÉS West-GlobeNewswire

MediPharm Announces Voting Results from the 2025 Annual and Special Meeting of Shareholders
17/06/2025
TORONTO, June 17, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“ MediPharm ” or the “ Company ”), a pharmaceutical company specialized in precision-based cannabinoids, today [...]
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
17/06/2025
Company Announcement COPENHAGEN, Denmark; June 17, 2025 – Genmab A/S (Nasdaq: GMAB) - In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document [...]
Singlera Genomics and Partners publish results from GUIDE prospective cohort study demonstrating blood-based early detection of gastrointestinal cancers using DNA methylation-based GutSeer assay
17/06/2025
SAN DIEGO and SHANGHAI, China, June 17, 2025 (GLOBE NEWSWIRE) -- Singlera Genomics, a biotechnology company focused on non-invasive early cancer detection, and Fudan University’s Zhongshan Hospital, a premier highly [...]
New Study Finds Cylinder’s Virtual Digestive Health Program Cuts Sick Days by 17% Among Older Workers
17/06/2025
Clinically validated GI care delivers measurable productivity gains and cost savings for employers CHICAGO, June 17, 2025 (GLOBE NEWSWIRE) -- Cylinder , the leading virtual digestive health provider, today announced new [...]
Press release: Transparency Notification from Shareholders
17/06/2025
Transparency Notification from Shareholders Ghent, Belgium – 17 June 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the " Company " or " Sequana Medical "), a pioneer in the treatment of drug-resistant fluid [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 24 - 2025
17/06/2025
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 09 juin au 13 juin 2025 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction Code [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 24 - 2025
17/06/2025
Aggregated presentation by day and by market Statement of transactions in own shares from June 09th to June 13th 2025 Name of the issuer Identity code of the issuer (Legal Entity Identifier) Day of the transaction [...]
PracticeLink Announces Inaugural First Practice Fund Scholarship Recipients, Celebrating Six Inspiring Medical Journeys
17/06/2025
ST. LOUIS and HINTON, West Virginia, June 17, 2025 (GLOBE NEWSWIRE) -- PracticeLink , the nation’s most trusted physician recruitment resource and home of the leading online physician job board, is proud to announce the [...]
EarlyHealth Group Acquires Corena to Drive $100M Growth in Türkiye’s Life Sciences Sector
17/06/2025
ANKARA, Türkiye, June 17, 2025 (GLOBE NEWSWIRE) -- EarlyHealth Group, a global pharmaceutical service provider, today announced the acquisition of Corena Ecza Deposu, Türkiye’s leading pharmaceutical distributor, [...]
Processa Pharmaceuticals Announces Pricing of $7 Million Public Offering
17/06/2025
HANOVER, Md., June 17, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (the “Company”), a clinical-stage pharmaceutical company developing Next Generation Cancer (NGC) therapies, today announced [...]
Precision Neuroscience Named to Fast Company’s World Changing Ideas and Inc.’s Best Workplaces Lists
17/06/2025
Awards recognize innovation in healthcare technology and excellence in workplace culture NEW YORK, June 17, 2025 (GLOBE NEWSWIRE) -- Precision Neuroscience Corporation (Precision), a leader in brain–computer interface ( [...]
Compass Health announces 2025 board of directors, bringing together accomplished leaders from regional, industry and nonprofit sectors
17/06/2025
EVERETT, Wash., June 17, 2025 (GLOBE NEWSWIRE) -- Today, Compass Health unveiled its 2025 board of directors, welcoming new members with expertise ranging from art therapy and healthcare marketing to strategic [...]
Slimjaro: Examining the Science and Safety of a Legal Slim Jaro Weight loss Health Formula
17/06/2025
Jacksonville, FL, June 17, 2025 (GLOBE NEWSWIRE) -- Weight loss is a humongous challenge that many people struggle with. Lack of motivation to continue a healthy lifestyle, diet, exercise, and hormonal imbalance, pave [...]
Endogenex to Present Data on Endoscopic Procedure for Type 2 Diabetes at American Diabetes Association’s (ADA) 85th Scientific Sessions
17/06/2025
MINNEAPOLIS, June 17, 2025 (GLOBE NEWSWIRE) -- Endogenex, a clinical-stage medical device company dedicated to improving outcomes in individuals with type 2 diabetes (T2D), will present results from its REGENT-1 [...]
Communiqué de presse : Sanofi place 1,5 milliard d’euros d’emprunts obligataires
17/06/2025
Sanofi place 1,5 milliard d’euros d’emprunts obligataires Paris, 17 juin 2025 - Sanofi annonce avoir placé avec succès une émission obligataire en 2 tranches (les « obligations ») pour un montant de 1,5 milliard d’euros [...]
Press release: Sanofi successfully prices €1.5 billion bond issue
17/06/2025
Sanofi successfully prices €1.5 billion bond issue Paris, June 17, 2025 - Sanofi announces that it has successfully priced its offering of €1.5 billion of notes across 2 tranches: €750 million fixed-rate notes, due June [...]
Aptose Provides Corporate Updates
17/06/2025
Announces short-term cash advance SAN DIEGO and TORONTO, June 17, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“ Aptose ” or the “ Company ”) (TSX: APS; OTC: APTOF), a clinical-stage precision oncology company, [...]
Saudi Arabia Introduces Strategic Healthcare Vision and Global Partnerships at BIO 2025
17/06/2025
BOSTON, June 17, 2025 (GLOBE NEWSWIRE) -- Saudi Arabia officially opened its national pavilion today at the BIO International Convention 2025, marking a milestone moment in its journey to become a global biotechnology [...]
Adial Pharmaceuticals Announces Pricing of $3.6 Million Public Offering
17/06/2025
GLEN ALLEN, Va., June 17, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and [...]

Pages